<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Medical literature is an important source of drug safety information relevant for signal detection, safety profile analysis and risk-benefit assessment. The main goal of our study was to assess the utility of domestic medical literature as a source of drug safety information. All safety information identified for active substances published between 1.01.2018-31.12.2019 in domestic medical journals published in Poland were analyzed. Four thousand seven hundred eighty-nine drug safety information was reported for 500 active substances. Two thousand and forty-four submissions dealing with drug safety (48.28%) were identified in the 10 journals from the list of analyzed journals (3 of these were identified in the 2019 JCR and 5 of these were indexed in the main scientific databases and 9 of these had an affiliation to scientific society). There was a correlation between journal impact factor and scientific database indexation with the number of published individual literature reports and type of safety information. Journals publishing in Polish constituted source for about 40% of all safety information published in the examined period. Journals indexed in Medline were the source of about 37% of all safety information while 42% was published in Embase. Local medical literature is a source of valuable safety information but the list of journals for monitoring should be carefully selected with particular attention to journals with impact factor.</p>
</abstract>

Medical literature is an important source of drug safety information relevant for signal detection, safety profile analysis and risk-benefit assessment. The main goal of our study was to assess the utility of domestic medical literature as a source of drug safety information. All safety information identified for active substances published between 1.01.2018-31.12.2019 in domestic medical journals published in Poland were analyzed. Four thousand seven hundred eighty-nine drug safety information was reported for 500 active substances. Two thousand and forty-four submissions dealing with drug safety (48.28%) were identified in the 10 journals from the list of analyzed journals (3 of these were identified in the 2019 JCR and 5 of these were indexed in the main scientific databases and 9 of these had an affiliation to scientific society). There was a correlation between journal impact factor and scientific database indexation with the number of published individual literature reports and type of safety information. Journals publishing in Polish constituted source for about 40% of all safety information published in the examined period. Journals indexed in Medline were the source of about 37% of all safety information while 42% was published in Embase. Local medical literature is a source of valuable safety information but the list of journals for monitoring should be carefully selected with particular attention to journals with impact factor.

The drug safety information in domestic medical literature

Department of Gastroenterology and Internal Diseases

Current Issues in Pharmacy and Medical Sciences

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"The drug safety information in domestic medical literature"}

Medical literature is an important source of drug safety information relevant for signal detection, safety profile analysis and risk-benefit assessment. The...

The drug safety information in domestic medical literature

Publicado en línea: 27 oct 2022

Páginas: 111 - 115

Recibido: 04 ene 2022

Aceptado: 02 sept 2022

DOI: https://doi.org/10.2478/cipms-2022-0021

Palabras clave
adverse drug event, adverse drug reaction, literature search, literature monitoring

© 2022 Bartlomiej Ochyra et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

The drug safety information in domestic medical literature

Publicado en línea: 27 oct 2022

Páginas: 111 - 115

Recibido: 04 ene 2022

Aceptado: 02 sept 2022

DOI: https://doi.org/10.2478/cipms-2022-0021

Palabras claveadverse drug event, adverse drug reaction, literature search, literature monitoring

© 2022 Bartlomiej Ochyra et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Palabras clave
adverse drug event, adverse drug reaction, literature search, literature monitoring